We also identified that METTL3 and IGF2BP2 mediated the m6A of FBXO43 and stabilizeD FBXO43 mRNA, which accounted for its upregulation and subsequently facilitated the METTL3 and IGF2BP2 oncogenic functions in HCC. The gene discussed is IGF2BP2; the disease is hepatocellular carcinoma.